David Shaw’s G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 GSQD.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-75,251
Closed -$5K 5564
2022
Q3
$5K Hold
75,251
﹤0.01% 5042
2022
Q2
$11K Hold
75,251
﹤0.01% 5137
2022
Q1
$30K Hold
75,251
﹤0.01% 5278
2021
Q4
$65K Hold
75,251
﹤0.01% 5151
2021
Q3
$79K Buy
+75,251
New +$79K ﹤0.01% 4758

Other funds holding GSQD.WS

David Shaw's GSQD.WS Position: Q4 2022 in Review

David Shaw sold out of G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 (GSQD.WS) in Q4 2022, closing a stake of 75,251 shares — an estimated $5K sold.

David Shaw first reported a position in GSQD.WS in Q3 2021 and held it in 5 quarters. The position peaked at $79K in Q3 2021. 6 funds tracked by Wall St. Rank hold GSQD.WS as of Q4 2022.

  • David Shaw reported no remaining G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • David Shaw sold 75,251 G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 shares in Q4 2022, an estimated $5K.
  • David Shaw first reported a position in G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 in Q3 2021 and held it in 5 quarters.
  • David Shaw's G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 position peaked at $79K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.